Navigation Links
Common blood pressure medication may pose risk to older adults
Date:6/16/2014

Dallas June 12, 2014 Adults over 65 who have recently begun thiazide diuretics are at a greater risk for developing metabolic-related adverse events, researchers at UTSouthwestern Medical Center have found.

More than two-thirds of older adults have high blood pressure in the United States and thiazide diuretics are often recommended as the initial medication for these hypertensive patients. Thiazide diuretics primarily inhibit sodium transport in the kidney, leading to urinary loss of sodium and water, which decreases blood pressure. While the risks of this medication are well known, the risks are not well quantified in real-world clinical practice, where older adults who are treated may have a number of other illnesses.

The national observational study, undertaken by a team of researchers at UTSouthwestern and the University of California, San Francisco, examined 1,060 adult veterans with hypertension who recently began taking a thiazide diuretic. The study compared them to a similar group of veterans who were not prescribed a thiazide diuretic. The findings were recently published in the Journal of the American Geriatrics Society.

During a nine month period, 14 percent of older adults prescribed a thiazide diuretic developed a metabolic adverse event, compared with 6 percent of adults not prescribed a thiazide diuretic. For every 12 adults who were newly prescribed a thiazide diuretic, one developed a metabolic adverse event that he or she would not otherwise have had.

The three metabolic adverse events that researchers assessed were hyponatremia (low sodium levels in the blood), hypokalemia (low potassium levels in the blood), and acute kidney injury (a 25 percent decrease in kidney function from the baseline value before the thiazide diuretic was started).

"Our research quantifies the risks of metabolic adverse events in older adults in real-world, clinical practice shortly after initiating thiazide diuretics," said Dr. Anil Makam, assistant professor of Internal Medicine at UTSouthwestern and first author of the study. "From a clinical point-of-view, the implications of these findings help inform doctors of the risks associated with a common medication and their use in older adults."

While the findings highlight that thiazide-related adverse events are common in this population, researchers were surprised to discover that only 42 percent of older adults who had recently begun taking a thiazide diuretic had laboratory testing to monitor for these adverse events within the first three months of beginning the medication.

"Our research suggests that thiazide-induced adverse events are common in older adults and greater attention should be paid to potential complications in prescribing thiazide diuretics to older adults, including closer laboratory monitoring before and after initiation of thiazides," Dr. Makam said.


'/>"/>
Contact: Lisa Warshaw
lisa.warshaw@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Researchers uncover common heart drugs link to diabetes
2. Compounds in saliva and common body proteins may fend off DNA-damaging chemicals
3. Creatures of habit: Disorders of compulsivity share common pattern and brain structure
4. Gambling history is common among homeless people in Toronto, new study
5. Study debunks common myth that urine is sterile
6. Discovery links rare, childhood neurodegenerative diseases to common problem in DNA repair
7. Expert guidance strengthens strategies to prevent most common and costly infection
8. Complications from kidney stone treatments are common and costly
9. Unemployment common after breast cancer treatment
10. Vanderbilt study finds physical signs of depression common among ICU survivors
11. Pregnancy complications may be more common in immigrants from certain regions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common blood pressure medication may pose risk to older adults
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary to popular perception, ... is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues ... violence in the United States. The study, Trends in Fighting and Violence ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Dudnyk has announced ... emphasizes the agency’s conviction that the full potential of specialty and orphan brands can ... appreciated and aligned. , “The Unifying Effect is at the heart of a ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... in the category of International Trade, the UK’s most prestigious award for business ... which represents 95% of total revenues and has grown by a total of ...
(Date:4/21/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, wrote ... global crisis with solution to peace plan. Yisrayl says war has never brought peace and ... by the Creator Himself. , Yisrayl says war drums are beating all over the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... 18, 2017 Research and Markets has ... States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... equipment revenues as well as growth in the number of ... value to market participants that design and manufacture molecular imaging ...
Breaking Medicine Technology: